Global Cimzia (certolizumab) Drug Market Research Report 2019
Table of Contents
Executive Summary
1 Cimzia (certolizumab) Drug Market Overview
- 1.1 Product Overview and Scope of Cimzia (certolizumab) Drug
- 1.2 Cimzia (certolizumab) Drug Segment by Type
- 1.2.1 Global Cimzia (certolizumab) Drug Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Crohn's Disease
- 1.2.3 Rheumatoid Arthritis
- 1.3 Cimzia (certolizumab) Drug Segment by Application
- 1.3.1 Cimzia (certolizumab) Drug Consumption Comparison by Application (2014-2025)
- 1.3.2 Crohn's Disease
- 1.3.3 Rheumatoid Arthritis
- 1.4 Global Cimzia (certolizumab) Drug Market by Region
- 1.4.1 Global Cimzia (certolizumab) Drug Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Cimzia (certolizumab) Drug Market Size
- 1.5.1 Global Cimzia (certolizumab) Drug Revenue (2014-2025)
- 1.5.2 Global Cimzia (certolizumab) Drug Production (2014-2025)
2 Global Cimzia (certolizumab) Drug Market Competition by Manufacturers
- 2.1 Global Cimzia (certolizumab) Drug Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Cimzia (certolizumab) Drug Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Cimzia (certolizumab) Drug Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Cimzia (certolizumab) Drug Production Sites, Area Served, Product Types
- 2.5 Cimzia (certolizumab) Drug Market Competitive Situation and Trends
- 2.5.1 Cimzia (certolizumab) Drug Market Concentration Rate
- 2.5.2 Cimzia (certolizumab) Drug Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Cimzia (certolizumab) Drug Production Market Share by Regions
- 3.1 Global Cimzia (certolizumab) Drug Production Market Share by Regions
- 3.2 Global Cimzia (certolizumab) Drug Revenue Market Share by Regions (2014-2019)
- 3.3 Global Cimzia (certolizumab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Cimzia (certolizumab) Drug Production
- 3.4.1 North America Cimzia (certolizumab) Drug Production Growth Rate (2014-2019)
- 3.4.2 North America Cimzia (certolizumab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Cimzia (certolizumab) Drug Production
- 3.5.1 Europe Cimzia (certolizumab) Drug Production Growth Rate (2014-2019)
- 3.5.2 Europe Cimzia (certolizumab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Cimzia (certolizumab) Drug Production (2014-2019)
- 3.6.1 China Cimzia (certolizumab) Drug Production Growth Rate (2014-2019)
- 3.6.2 China Cimzia (certolizumab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Cimzia (certolizumab) Drug Production (2014-2019)
- 3.7.1 Japan Cimzia (certolizumab) Drug Production Growth Rate (2014-2019)
- 3.7.2 Japan Cimzia (certolizumab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Cimzia (certolizumab) Drug Consumption by Regions
- 4.1 Global Cimzia (certolizumab) Drug Consumption by Regions
- 4.2 North America Cimzia (certolizumab) Drug Consumption (2014-2019)
- 4.3 Europe Cimzia (certolizumab) Drug Consumption (2014-2019)
- 4.4 China Cimzia (certolizumab) Drug Consumption (2014-2019)
- 4.5 Japan Cimzia (certolizumab) Drug Consumption (2014-2019)
5 Global Cimzia (certolizumab) Drug Production, Revenue, Price Trend by Type
- 5.1 Global Cimzia (certolizumab) Drug Production Market Share by Type (2014-2019)
- 5.2 Global Cimzia (certolizumab) Drug Revenue Market Share by Type (2014-2019)
- 5.3 Global Cimzia (certolizumab) Drug Price by Type (2014-2019)
- 5.4 Global Cimzia (certolizumab) Drug Production Growth by Type (2014-2019)
6 Global Cimzia (certolizumab) Drug Market Analysis by Applications
- 6.1 Global Cimzia (certolizumab) Drug Consumption Market Share by Application (2014-2019)
- 6.2 Global Cimzia (certolizumab) Drug Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Cimzia (certolizumab) Drug Business
- 7.1 UCB
- 7.1.1 UCB Cimzia (certolizumab) Drug Production Sites and Area Served
- 7.1.2 Cimzia (certolizumab) Drug Product Introduction, Application and Specification
- 7.1.3 UCB Cimzia (certolizumab) Drug Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
8 Cimzia (certolizumab) Drug Manufacturing Cost Analysis
- 8.1 Cimzia (certolizumab) Drug Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Cimzia (certolizumab) Drug
- 8.4 Cimzia (certolizumab) Drug Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Cimzia (certolizumab) Drug Distributors List
- 9.3 Cimzia (certolizumab) Drug Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Cimzia (certolizumab) Drug Market Forecast
- 11.1 Global Cimzia (certolizumab) Drug Production, Revenue Forecast
- 11.1.1 Global Cimzia (certolizumab) Drug Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Cimzia (certolizumab) Drug Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Cimzia (certolizumab) Drug Price and Trend Forecast (2019-2025)
- 11.2 Global Cimzia (certolizumab) Drug Production Forecast by Regions (2019-2025)
- 11.2.1 North America Cimzia (certolizumab) Drug Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Cimzia (certolizumab) Drug Production, Revenue Forecast (2019-2025)
- 11.2.3 China Cimzia (certolizumab) Drug Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Cimzia (certolizumab) Drug Production, Revenue Forecast (2019-2025)
- 11.3 Global Cimzia (certolizumab) Drug Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Cimzia (certolizumab) Drug Consumption Forecast (2019-2025)
- 11.3.2 Europe Cimzia (certolizumab) Drug Consumption Forecast (2019-2025)
- 11.3.3 China Cimzia (certolizumab) Drug Consumption Forecast (2019-2025)
- 11.3.4 Japan Cimzia (certolizumab) Drug Consumption Forecast (2019-2025)
- 11.4 Global Cimzia (certolizumab) Drug Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Cimzia (certolizumab) Drug Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Certolizumab pegol is a TNF (tumor necrosis factor) inhibitor that is primarily used to treat Crohns disease. Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha (TNF-alfa). In 2008, it was approved for rheumatoid arthritis treatment under the brand CIMZIA®. It was used off-label to treat psoriatic arthritis until it was approved for this indication in 2013.
The global Cimzia (certolizumab) Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cimzia (certolizumab) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cimzia (certolizumab) Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
UCB
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Crohn's Disease
Rheumatoid Arthritis
Segment by Application
Crohn's Disease
Rheumatoid Arthritis